- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02306200
Cardiovascular Health Improvement Project (CHIP)
May 31, 2023 updated by: Marion Hofmann Bowman, University of Michigan
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
Study Overview
Status
Recruiting
Detailed Description
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
The aims of the study are to collect biological specimens (blood, plasma, serum, aortic tissue) and family history; establish a biobank, establish a comprehensive database with information from consented patients, and provide researchers with high quality well annotated DNA samples with demographic and clinical information.
Study Type
Observational
Enrollment (Estimated)
9999
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lauren Humphrey-Stark, BS
- Phone Number: 7342324779
- Email: ljeany@med.umich.edu
Study Contact Backup
- Name: Jen McNamara, MS
- Phone Number: 734-232-6180
- Email: jlmcnama@med.umich.edu
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Recruiting
- University of Michigan
-
Contact:
- Jen McNamara, MS
- Phone Number: 734-232-6180
- Email: jlmcnama@med.umich.edu
-
Contact:
- Lauren Humphrey-Stark, BS
- Phone Number: 734-232-4779
- Email: ljeany@med.umich.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Outpatient clinic
Description
Inclusion Criteria:
- Any patient over the age of 18 who is able/willing to give informed consent
- Patients <18 years of age with parental consent and assent (if assent is applicable for their age)
- Diagnosis of:
- aortic pathology potentially due to a known or suspected inherited condition
- Idiopathic aortic aneurysm
- Interesting of novel vascular pathology in the aorta or main branches
- Family history of aortic or vascular disease
- Other cardiovascular disease
- Healthy controls with no apparent cardiovascular disease
Exclusion Criteria:
- Not willing or able to sign the consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Aortic Disease
Patients with a diagnosis of any form of Aortic Disease
|
Controls
Patients without a diagnosis of Aortic Disease
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Establishing a biobank of patients with Aortic Disease
Time Frame: 40 years
|
Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease
|
40 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marion A Hofmann Bowman, PhD, MD, University of Michigan
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Estimated)
August 1, 2050
Study Completion (Estimated)
August 1, 2050
Study Registration Dates
First Submitted
December 1, 2014
First Submitted That Met QC Criteria
December 1, 2014
First Posted (Estimated)
December 3, 2014
Study Record Updates
Last Update Posted (Actual)
June 1, 2023
Last Update Submitted That Met QC Criteria
May 31, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Heart Diseases
- Vascular Diseases
- Congenital Abnormalities
- Aortic Valve Disease
- Heart Valve Diseases
- Heart Defects, Congenital
- Cardiovascular Abnormalities
- Aortic Diseases
- Dissection, Blood Vessel
- Acute Aortic Syndrome
- Cardiovascular Diseases
- Aneurysm
- Bicuspid Aortic Valve Disease
- Aortic Aneurysm
- Aortic Dissection
Other Study ID Numbers
- HUM00052866
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted